Anika Therapeutics | ANIK - Market Capitalization


Anika Therapeutics reported $306.7M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 171.01B 12.96B Sep/2026
Agenus USD 128M 21M Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 24.93B 1.82B Sep/2026
Integra LifeSciences USD 1.27B 131M Sep/2026
J&J USD 653.61B 42.25B Sep/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Ligand Pharmaceuticals USD 6.23B 108M Sep/2026
MacroGenics USD 151M 143M Nov/2026
Merit Medical Systems USD 5.15B 1.01B Sep/2026
Sanofi EUR 100.56B 13.53B Nov/2026
Smith & Nephew USD 12.7B 621.83M Jun/2026
Stryker USD 105.63B 15.07B Sep/2026
Veracyte USD 4.69B 2.12B Jun/2026
Xencor USD 1.19B 301M Jun/2026
Zimmer Biomet Holdings USD 16.66B 845M Jun/2026